Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
42.59
-1.89 (-4.25%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,940 | 3,882 | 3,926 | 3,248 | 5,732 | 9,158 | |
| Market Cap Growth | -1.13% | -1.13% | 20.88% | -43.33% | -37.41% | 271.16% | |
| Enterprise Value | 4,105 | 3,991 | 4,355 | 3,149 | 5,183 | 8,768 | |
| Last Close Price | 42.59 | 42.07 | 47.82 | 46.33 | 84.09 | 138.43 | |
| PS Ratio | 6.88 | 6.93 | 9.04 | 8.94 | 16.31 | 33.79 | |
| PB Ratio | 15.43 | 10.97 | 14.26 | 9.21 | 6.21 | 7.93 | |
| P/TBV Ratio | 28.24 | 28.24 | 60.65 | 21.95 | 7.67 | 9.36 | |
| EV/Sales Ratio | 7.33 | 7.12 | 10.03 | 8.67 | 14.75 | 32.35 | |
| Debt / Equity Ratio | 2.58 | 2.58 | 3.39 | 2.57 | 0.43 | 0.33 | |
| Asset Turnover | - | - | 0.29 | 0.24 | 0.21 | 0.19 | |
| Inventory Turnover | - | - | 22.84 | 34.15 | 35.05 | 34.01 | |
| Quick Ratio | - | - | 2.32 | 3.04 | 4.33 | 6.51 | |
| Current Ratio | - | - | 2.61 | 3.38 | 4.72 | 6.83 | |
| Return on Equity (ROE) | -180.91% | -180.91% | -193.23% | -110.96% | -43.72% | -20.64% | |
| Return on Assets (ROA) | - | - | -23.43% | -26.44% | -14.54% | -14.25% | |
| Return on Capital (ROIC) | -27.05% | -27.05% | -28.81% | -31.49% | -16.72% | -16.22% | |
| Earnings Yield | -14.45% | -14.66% | -15.45% | -21.78% | -7.92% | -2.04% | |
| FCF Yield | - | -13.22% | -15.29% | -7.18% | -1.92% | |
| Buyback Yield / Dilution | -23.11% | -23.11% | -5.19% | -3.13% | -11.42% | -7.54% | |
| Total Shareholder Return | -23.11% | -23.11% | -5.19% | -3.13% | -11.42% | -7.54% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.